產(chǎn)品編號(hào) | 圖片 | CAS No. | 名稱及描述 | 價(jià)格 | 分子式 | 快速訂購 |
---|---|---|---|---|---|---|
CL1948A |
|
356559-13-2 |
SB-505124 HCl SB-505124 hydrochloride - 98+% |
需詢價(jià) | C20H22ClN3O2 | |
CL1270A |
|
924898-09-9 |
LY2157299 monohydrate Galunisertib monohydrate | LY2157299 monohydrate - 98+% |
需詢價(jià) | C22H19N5O.H2O | |
CL2608 |
|
123-78-4 |
D-神經(jīng)鞘氨醇 | D-鞘氨醇 | (2S,3R,4E)-2-氨基-4-十八碳烯-1,3-二醇 D-erythro-Sphingosine | (2S,3R,4E)-2-Amino-4-Octadecene-1,3-Diol | (E,2S,3R)-2-Aminooctadec-4-Ene-1,3-Diol | D-erythro-Sphingosine(DES) 3-5days 98+% |
¥378.00 | C18H37NO2 | |
CL2598 |
|
909910-43-6 |
A 83-01 | A-83-01 A 83-01 | A-83-01 - 98+% |
需詢價(jià) | C25H19N5S | |
CL2440 |
|
133053-19-7 |
Go 6983 Go 6983 In-stock 98+% |
¥600.00 | C26H26N4O3 | |
HL1439 |
|
16837-52-8 |
氧化苦參堿丨苦參素 Oxymatrine In-stock 98+% |
¥600.00 | C15H24N2O2 | |
CLA1323 |
|
1356922-05-8 |
比瑪盧單抗 Bimagrumab (Anti-ACVR2B) 3-5days 95+% |
¥3000.00 | — | |
CLA1157 |
|
705287-60-1 |
司他蘆單抗 Stamulumab (Synonyms: MYO-029) 3-5days 95+% |
¥9000.00 | — | |
CLA1151 |
|
272780-74-2 |
美替木單抗 Metelimumab 3-5days 95+% |
¥3000.00 | — | |
CLA1147 |
|
285985-06-0 |
樂德木單抗 Lerdelimumab 3-5days 95+% |
¥9000.00 | — | |
CLA1141 |
|
948564-73-6 |
非蘇木單抗 Fresolimumab 3-5days 95+% |
¥6000.00 | — | |
CL2227 |
|
1246304-91-5 |
Roy-Bz Roy-Bz 3-5days 98+% |
¥3200.00 | C36H38O8 | |
CL2215 |
|
521984-48-5 |
SIS3 鹽酸鹽 SIS3 HCl In-stock 98+% |
¥1000.00 | C28H28ClN3O3 | |
CL1934 |
|
497259-23-1 |
TPPB (α-Amyloid Precursor Protein Modulator) TPPB (α-Amyloid Precursor Protein Modulator) - 98+% |
需詢價(jià) | C27H30F3N3O3 | |
CL1227 |
|
56124-62-0 |
戊柔比星 Valrubicin | AD-32 - 98+% |
需詢價(jià) | C34H36F3NO13 | |
CL1270 |
|
700874-72-2 |
LY2157299 Galunisertib | LY2157299 3-5days 98+% |
¥466.00 | C22H19N5O | |
CL1082 |
|
301836-41-9 |
SB-431542 SB-431542 In-stock 98+% |
¥350.00 | C22H16N4O3 | |
CL1542 |
|
1062368-24-4 |
4-[6-(4-(哌嗪-1-基)苯基]吡唑并[1,5-a]嘧啶-3-基)喹啉 LDN-193189(DM3189) In-stock 98+% |
¥750.00 | C25H22N6 | |
CL1057 |
|
1206711-16-1 |
DMH-1 DMH-1 (DMH1) In-stock 98+% |
¥400.00 | C24H20N4O | |
CL1556 |
|
1432597-26-6 |
5-[6-[4-(1-哌嗪基)苯基]吡唑并[1,5-a]嘧啶-3-基]喹啉 LDN-212854 | BMP Inhibitor III | LDN 212854 | 5-[6-[4-(1-Piperazinyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]quinoline - 98+% |
需詢價(jià) | C25H22N6 | |